HERON THERAPEUTICS, INC. /DE/ (HRTX) Operating income 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) annual operating income history from SEC filings — each fiscal year as reported.
-$2.5MFY2025 · since FY2016: -$170.9M → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.5M | +78.0% |
| FY2024 | -$11.5M | +89.6% |
| FY2023 | -$110.6M | +36.7% |
| FY2022 | -$174.7M | +19.8% |
| FY2021 | -$217.8M | +4.5% |
| FY2020 | -$228.2M | -8.3% |
| FY2019 | -$210.7M | -14.5% |
| FY2018 | -$183.9M | +5.5% |
| FY2017 | -$194.6M | -13.8% |
| FY2016 | -$170.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice